Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
The latest announcement is out from Auna S.A. Class A ( (AUNA) ).
On June 30, 2025, Auna S.A. announced that its controlling shareholder, Enfoca, has successfully refinanced its sponsor-level financing, extending the maturity date to June 2027 with improved economic terms. This refinancing strengthens the alignment between Auna and its pre-IPO shareholders, supporting the company’s strategic growth initiatives in Latin America.
The most recent analyst rating on (AUNA) stock is a Hold with a $7.90 price target. To see the full list of analyst forecasts on Auna S.A. Class A stock, see the AUNA Stock Forecast page.
Spark’s Take on AUNA Stock
According to Spark, TipRanks’ AI Analyst, AUNA is a Neutral.
The overall score reflects a strong financial performance with solid revenue growth and profitability improvements. However, technical analysis shows bearish momentum, and valuation metrics are reasonable but not compelling. Continued focus on reducing leverage and enhancing market sentiment could improve the stock’s outlook.
To see Spark’s full report on AUNA stock, click here.
More about Auna S.A. Class A
Auna S.A. is a leading healthcare platform in Latin America, operating in Mexico, Peru, and Colombia. The company focuses on prevention and high-complexity diseases, providing a comprehensive healthcare offering in underpenetrated Spanish-speaking markets. Founded in 1989, Auna has developed a large healthcare network with 31 facilities and 1.4 million healthcare plans.
Average Trading Volume: 30,450
Technical Sentiment Signal: Sell
Current Market Cap: $469.2M
See more data about AUNA stock on TipRanks’ Stock Analysis page.